Fetal BloodPeripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationStem CellsSpinal CordTransplantation, AutologousHematopoietic Stem CellsTransplantation, HomologousHematopoietic Stem Cell MobilizationAntigens, CD34Spinal Cord InjuriesCord Blood Stem Cell TransplantationGraft SurvivalKidney TransplantationGranulocyte Colony-Stimulating FactorLeukapheresisTransplantation ConditioningStem Cell TransplantationGraft vs Host DiseaseTissue DonorsTransplantsUmbilical CordBone Marrow TransplantationHematologic NeoplasmsBlood BanksImmunosuppressive AgentsBlood Component RemovalGraft RejectionTreatment OutcomeHistocompatibility TestingInfant, NewbornTime FactorsBlood CellsPlant StemsMelphalanHematopoiesisHeart TransplantationCombined Modality TherapyHistocompatibilityRetrospective StudiesBlood Cell CountAdult Stem CellsCyclophosphamideTransplantationNeoplastic Stem CellsTransplantation ChimeraBusulfanColony-Forming Units AssayCells, CulturedPregnancyRecurrenceStem Cell FactorLung TransplantationCyclosporineCell SeparationMultiple MyelomaCytomegalovirus InfectionsFlow CytometryCell DifferentiationLeukemiaBone Marrow CellsPluripotent Stem CellsCell LineageAntineoplastic Combined Chemotherapy ProtocolsMyeloablative AgonistsImmunophenotypingWhole-Body IrradiationImmunosuppressionTacrolimusAntigens, CDMice, SCIDNeural Stem CellsSurvival RateInduced Pluripotent Stem CellsInfectionHLA AntigensBlood DonorsTissue and Organ ProcurementFollow-Up StudiesFetal Tissue TransplantationLymphoma, Non-HodgkinMaternal-Fetal ExchangeTransplantation ImmunologyMice, Inbred NODStem Cell NicheSurvival AnalysisMesenchymal Stromal CellsAntineoplastic Agents, AlkylatingMesenchymal Stem Cell TransplantationThiotepaSpinal Cord DiseasesHematologic DiseasesBlood PreservationEtoposideLiving DonorsPostoperative ComplicationsMultipotent Stem CellsProspective StudiesAnemia, AplasticDisease-Free Survival